Abstract:The structural similarity between defensins and scorpion neurotoxins suggests that they might have evolved from a common ancestor. However, there is no direct experimental evidence demonstrating a functional link between scorpion neurotoxins and defensins. The scorpion defensin BmKDfsin4 from Mesobuthus martensiiKarsch contains 37 amino acid residues and a conserved cystine-stabilized α/β structural fold. The recombinant BmKDfsin4, a classical defensin, has been found to have inhibitory activity against Gram-positive bacteria such as Staphylococcus aureus, Bacillus subtilis, and Micrococcus luteusas well as methicillin-resistant Staphylococcus aureus Interestingly, electrophysiological experiments showed that BmKDfsin4,like scorpion potassium channel neurotoxins, could effectively inhibit Kv1.1, Kv1.2, and Kv1.3 channel currents, and its IC50value for the Kv1.3 channel was 510.2 nm Similar to the structure-function relationships of classical scorpion potassium channel-blocking toxins, basic residues (Lys-13 and Arg-19) of BmKDfsin4 play critical roles in peptide-Kv1.3 channel interactions. Furthermore, mutagenesis and electrophysiological experiments demonstrated that the channel extracellular pore region is the binding site of BmKDfsin4, indicating that BmKDfsin4 adopts the same mechanism for blocking potassium channel currents as classical scorpion toxins. Taken together, our work identifies scorpion BmKDfsin4 as the first invertebrate defensin to block potassium channels. These findings not only demonstrate that defensins from invertebrate animals are a novel type of potassium channel blockers but also provide evidence of a functional link between defensins and neurotoxins.

Pharmacological Characterization of Human Beta-Defensins 3 and 4 on Potassium Channels: Evidence of Diversity in Beta-Defensin-potassium Channel Interactions.

Human beta-defensin 1, a new animal toxin-like blocker of potassium channel

Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels.

Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels

Human Α‐defensins Are Immune‐related Kv1.3 Channel Inhibitors: New Support for Their Roles in Adaptive Immunity

Endogenous Animal Toxin-Like Human Β-Defensin 2 Inhibits Own K+ Channels Through Interaction with Channel Extracellular Pore Region

Human Β-Defensin 2 is a Novel Opener of Ca 2+ -Activated Potassium Channels and Induces Vasodilation and Hypotension in Monkeys

Defensins, a novel type of animal toxin-like potassium channel inhibitor

Kv Channel S1-S2 Linker Working As a Binding Site of Human Β-Defensin 2 for Channel Activation Modulation*

Plectasin, First Animal Toxin-Like Fungal Defensin Blocking Potassium Channels Through Recognizing Channel Pore Region.

A-Type Kv4 Channel Closed-State Inactivation is Modulated by the Tetramerization Domain Interacting with Auxilary KChIP4a

Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation

Comparison of Binding and Block Produced by Alternatively Spliced Kvβ1 Subunits

Structural Basis for Toxin Resistance of Β4-Associated Calcium-activated Potassium (BK) Channels

Antimicrobial Characterization of Human -Defensin 3 Derivatives

Antimicrobial Activity of Human Β-Defensins Against Lactic Acid Bacteria

Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin

Structure of Lymphocyte Potassium Channel K V1.3 and Modulation by Cell-Penetrating Immunomodulatory Plant Defensin

A Chimeric Cationic Peptide Composed of Human β-Defensin 3 and Human β-Defensin 4 Exhibits Improved Antibacterial Activity and Salt Resistance

Discovery of agonist-antagonist pairs for the modulation of Ca [2]+ and voltage-gated K+ channels of large conductance that contain beta1 subunits

Separable Kv Beta Subunit Domains Alter Expression And Gating Of Potassium Channels